<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="79472">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02070861</url>
  </required_header>
  <id_info>
    <org_study_id>2013/1605</org_study_id>
    <nct_id>NCT02070861</nct_id>
  </id_info>
  <brief_title>Non-invasive Evaluation of Volume Status Using End-tidal CO2 and Pulse Contour Analysis</brief_title>
  <official_title>Non-invasive Volume Evaluation With Endtidal CO2 and Pulse Contour Analysis (Nexfin)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Norwegian Air Ambulance Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that exhaled CO2 reflect changes in blood circulation due to
      changes in lung circulation, provided CO2-production in the tissues and ventilation from the
      lungs are stable. The investigators want to investigate this in patients using different
      devices: a finger cuff measuring blood pressure and cardiac output (the amount of blood
      being pumped out of the heart each minute), an esophagus ultra sound device measuring
      cardiac output, and exhaled carbondioxide in the patients` breath measured by the
      ventilator.

      The investigators investigate patients undergoing bypass surgery on the heart, as they
      undergo relevant changes in blood circulation during their operation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in cardiac output</measure>
    <time_frame>5 Minutes</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Changes in Cardiac Output</condition>
  <arm_group>
    <arm_group_label>Endtidal CO2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One arm,</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Changes in cardiac output</intervention_name>
    <arm_group_label>Endtidal CO2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Persons 18 years or older scheduled to undergo arteriocoranary bypass surgery.

        Exclusion Criteria:

          -  Esophageal pathology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Oslo University Hospital, Ullev√•l</name>
      <address>
        <city>Oslo</city>
        <zip>0454</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0876</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 19, 2016</lastchanged_date>
  <firstreceived_date>February 23, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Ingrid Elise Hoff</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Cardiac output</keyword>
  <keyword>Endtidal CO2</keyword>
  <keyword>Nexfin</keyword>
  <keyword>Esophageal Doppler</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
